Paper227992
Evidence for herpes simplex virus type-selective receptors on cellular plasma membranes.
Vahlne A and 2 others. J Gen Virol, 1979. Cited by 71 papers, by iCite.
Cite this record
ConductScience Library. Evidence for herpes simplex virus type-selective receptors on cellular plasma membranes. Papers, record 227992. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/227992
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Membrane | Major topic |
| Receptors, Virus | Major topic |
| Simplexvirus | Major topic |
| Adsorption | |
| Animals | |
| Cell Line | |
| Cornea | |
| Haplorhini | |
| HeLa Cells | |
| Humans | |
| Kidney | |
| Laryngeal Neoplasms | |
| Lung | |
| Rabbits | |
| Viral Interference | |
| Virus Replication |
Source PubMed
Cited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 11435568 | Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. | J Virol | 2001 | https://conductscience.org/library/papers/11435568 | PubMed |
| 8985338 | Dextran sulfate can act as an artificial receptor to mediate a type-specific herpes simplex virus infection via glycoprotein B. | J Virol | 1997 | https://conductscience.org/library/papers/8985338 | PubMed |
| 8648678 | Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry. | J Virol | 1996 | https://conductscience.org/library/papers/8648678 | PubMed |
| 8386261 | Resistance of herpes simplex virus type 2 to neomycin maps to the N-terminal portion of glycoprotein C. | J Virol | 1993 | https://conductscience.org/library/papers/8386261 | PubMed |
| 8017175 | Resistance of rat CNS to brain stem infection with herpes simplex virus type 1. | Acta Neuropathol | 1994 | https://conductscience.org/library/papers/8017175 | PubMed |
| 7866875 | Herpes simplex virus vectors for gene therapy. | Mol Biotechnol | 1994 | https://conductscience.org/library/papers/7866875 | PubMed |
| 7724595 | Infection of cells by varicella zoster virus: inhibition of viral entry by mannose 6-phosphate and heparin. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7724595 | PubMed |
| 6320772 | Early interactions between human cytomegalovirus and cells. | Arch Virol | 1984 | https://conductscience.org/library/papers/6320772 | PubMed |
| 6295978 | Interaction of viruses with cell surface receptors. | Int Rev Cytol | 1982 | https://conductscience.org/library/papers/6295978 | PubMed |
| 6290397 | Early interactions of herpes simplex virus with mouse peritoneal macrophages. | Infect Immun | 1982 | https://conductscience.org/library/papers/6290397 | PubMed |
| 6249749 | Differences in attachment between herpes simplex type 1 and type 2 viruses to neurons and glial cells. | Infect Immun | 1980 | https://conductscience.org/library/papers/6249749 | PubMed |
| 3310033 | Inhibitors of protein glycosylation and glycoprotein processing in viral systems. | Pharmacol Ther | 1987 | https://conductscience.org/library/papers/3310033 | PubMed |
| 3027364 | Structure and expression of the herpes simplex virus type 2 glycoprotein gB gene. | J Virol | 1987 | https://conductscience.org/library/papers/3027364 | PubMed |
| 3026331 | Polyphosphoinositide metabolism in baby-hamster kidney cells infected with herpes simplex virus type 1. | Biochem J | 1986 | https://conductscience.org/library/papers/3026331 | PubMed |
| 2993660 | Virion component of herpes simplex virus type 1 KOS interferes with early shutoff of host protein synthesis induced by herpes simplex virus type 2 186. | J Virol | 1985 | https://conductscience.org/library/papers/2993660 | PubMed |
| 2991570 | Specificities of monoclonal and polyclonal antibodies that inhibit adsorption of herpes simplex virus to cells and lack of inhibition by potent neutralizing antibodies. | J Virol | 1985 | https://conductscience.org/library/papers/2991570 | PubMed |
| 2846873 | Herpes simplex viruses lacking glycoprotein D are unable to inhibit virus penetration: quantitative evidence for virus-specific cell surface receptors. | J Virol | 1988 | https://conductscience.org/library/papers/2846873 | PubMed |
| 2822948 | Evidence that neomycin inhibits binding of herpes simplex virus type 1 to the cellular receptor. | J Virol | 1987 | https://conductscience.org/library/papers/2822948 | PubMed |
| 2535752 | Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. | J Virol | 1989 | https://conductscience.org/library/papers/2535752 | PubMed |
| 2444713 | Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. | J Virol | 1987 | https://conductscience.org/library/papers/2444713 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/227992
GET https://conductscience.org/api/papers/v1/227992/cited_by?page=2